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 Obesity, apolipoprotein E ε4 and difficulties in activities of daily living among older adults: 
A six-year follow-up study 
Abstract 
Background: Obesity has been associated with increased physical limitations among older adults, 
although few studies have adjusted for important covariates. There is limited information about 
the relationship between APOE polymorphisms and physical limitations, and the findings have 
been inconsistent. 
Purpose: This study examined the longitudinal associations of obesity and APOE ε4 with 
difficulties in activities of daily living (ADLs) over a six-year follow-up period controlling for 
multiple covariates. 
Methods: Data were analyzed from the Social Environment and Biomarkers of Aging Study 
(SEBAS) in Taiwan collected in 2000 and 2006, involving a cohort of 639 participants (mean age 
= 66). Body mass index (BMI) was used to define obesity at baseline and the APOE genotype 
was classified into APOE ε4 carrier and non-carrier status. The combination of basic and 
instrumental activities of daily living (ADLs and IADLs) was used to define impaired ADLs.  
Results: APOE ε4 carriers had greater difficulties in combined ADLs (Incident rate ratio; IRR 
=1.87, 95 % CI =1.40–2.51) than non-carriers. Obese but not overweight adults had greater 
difficulties in activities of daily living (IRR =1.59, 95 % CI =1.20–2.10) compared with the 
normal/underweight group. Obese older adults without APOE ε4 had greater subsequent 
 difficulties in ADLs than non-obese non-carriers. Among APOE ε4 carriers, obesity was not a 
significant risk factor for the development of impaired ADLs in older adults, indicating an 
interaction between genotype and obesity. 
Conclusions: The interaction between genotype and obesity phenotype adds new information 
about the determinants of physical impairment. 
Keywords: Physical disability; physical function; mobility; weight status; overweight 
 Obesity, apolipoprotein E ε4 and difficulties in activities of daily living among older adults: 
A six-year follow-up study 
Introduction 
Physical disability, an umbrella term for impairments, activity limitations, or participation 
restrictions [1], is an important determinant of quality of life in aging [2]. There is abundant 
evidence that obesity is associated with increased physical disability among older adults [3-5]. 
Individuals with obesity are at high risk of falls, injuries, and mobility disability [6]. However, 
few studies have adjusted for important covariates such as physical activity, cognitive function, 
depressive symptoms, and chronic diseases, even though these may play a role in the relationship 
between obesity and physical limitations [3, 7]. No research has further included biomarkers in a 
single study, even though factors such as homocysteine [8] and C-reactive protein (CRP) [9, 10] 
appear to be associated with physical limitations in older adults. 
The role of heredity in physical limitations in aging is also not fully understood. The 
apolipoprotein E (APOE) gene has been linked to cognitive function and mortality, with the 
APOE ε4 polymorphism being associated with poor cognitive performance [11, 12] and higher 
risk of death [13]. Only a few studies have examined the relationship between APOE 
polymorphisms and physical limitations, and the findings have been inconsistent. Some studies 
have found significant associations between APOE ε4 and increased difficulties in ADLs [12, 14], 
while others have not [15-17]. The associations between APOE ε4 carrier status and physical 
limitations remain unclear. Additionally, no study has examined the associations between the 
 combination of obesity and APOE ε4 in relation to physical limitations. To fill this gap in the 
literature, we examined the longitudinal associations of obesity and APOE ε4 with difficulties in 
activities of daily living among older adults controlling for a number of covariates over a six-year 
follow-up period. 
Methods 
Participants 
Data used in this study were retrieved from the Social Environment and Biomarkers of 
Aging Study (SEBAS), a nationally representative longitudinal survey of older adults in Taiwan 
that included in-home interviews and hospital-based physical examinations. The SEBAS is an 
extension of the Taiwan Longitudinal Study on Aging (TLSA). The TLSA, beginning in 1989, 
was a nationally representative cohort of the non-institutionalized population aged 60 and older, 
with younger refresher cohorts (age 50-66) being added in 1996. The 1999 TLSA included both 
participants from the 1989 and 1996 TLSA (n=4440). In 2000, participants were randomly 
selected from the 1999 TLSA for the SEBAS, representing a national sample of Taiwanese adults 
aged 54 and older [18]. A total of 1497 participants were interviewed and 1023 of them 
participated in the physical examination in the SEBAS 2000. The second wave of SEBAS was 
conducted in 2006 with 757 participants (89.5% response rate among survivors) being 
interviewed and 639 of them completing the hospital-based physical examinations [19]. Our 
analytic cohort was limited to 639 participants aged 54 to 80 (mean age = 66) with complete 
information on interviews and medical examinations in both SEBAS surveys. This study was 
 approved by the Institutional review board at Antai Medical Care Cooperation Antai Tian-Sheng 
Memorial Hospital in Taiwan. 
Both waves of SEBAS included self-reported social-demographic variables, health-related 
behaviors (e.g. smoking, alcohol consumption, and exercise), health conditions (e.g. chronic 
disease, activity of daily living, depressive symptoms, cognitive function), and genetic and 
biological markers from blood and urine samples. More detailed information is provided 
elsewhere [17, 19, 20]. 
Measures 
Obesity 
Height and weight were measured during physical examinations at baseline in 2000. Body 
mass index (BMI) was calculated as weight in kilograms divided by the square of height in 
meters (kg/m2). The World Health Organization BMI classifications of obesity reflect risks for 
type 2 diabetes and cardiovascular diseases, which varies among ethnic groups [21]. Therefore, 
the national criteria of obesity in Taiwan [22] were used to determine underweight, normal, 
overweight, obesity classifications (obesity ≥27, overweight 24–26.99, normal 18.5–23.99, and 
underweight <18.5). As prevalence of underweight was very low (2.3%; n=15), the normal and 
underweight figures were combined and subsequently referred to as ‘normal/underweight’. 
Apolipoprotein E genotypes 
The technique for determining APOE genotypes has been described in previous studies [23, 
24]. Briefly, deoxyribonucleic acid (DNA) was extracted from whole blood and APOE was 
 genotyped using the polymerase chain reaction (PCR) amplification refractory mutation system 
and PCR restriction fragment length polymorphism analysis. APOE genotypes were classified 
into two groups, since this study focused on examining the associations between APOE ε4 and 
ADL difficulties. Individuals with at least one APOE ε4 allele were defined as APOE ε4 carriers 
and those without an APOE ε4 allele were defined as non-carriers. 
Activities of daily living 
Participants were asked to self-report any difficulty they experienced in basic ADLs [25] 
and instrumental activities of daily living (IADLs) [26] in both 2000 and 2006 surveys. Basic 
ADLs comprise six types of self-care activities, including dressing and undressing, eating, 
bathing or showering, walking indoors, getting out of bed and standing up or sitting in a chair, 
and using the toilet. IADLs include activities of shopping, using public transport, managing 
money, doing heavy housework, doing light housework, and making phone calls. Each item was 
rated as not difficult (0), a little difficult (1), very difficult (2), and cannot perform at all (3). A 
combination of basic ADLs and IADLs has been recommended for the assessment of functional 
impairment to enhance range and sensitivity of measurement [27] and has been used in previous 
studies [28, 29]. Therefore, this study used the combination scores of basic ADLs and IADLs 
(range 0 to 36) to define difficulties in ADLs, with higher scores indicating a higher degree of 
difficulty. The combination of ADLs and IADLs measured in 2006 was the outcome variable and 
the combination of baseline ADLs and IADLs measured in 2000 was included as a covariate. 
Covariates 
 Socio-demographic variables included age (<65, 65-74, ≥75), sex, years of schooling (no 
schooling, 1-6 years, ≥7 years), and marital status (married, all others).  
Three health-related behaviors (smoking, alcohol consumption, and exercise) were recoded 
into binary variables (yes, no). The following questions were asked: “In the past six months, did 
you smoke?” “In the past six months, did you drink alcohol?” [30]. Participants reported the 
frequency of exercise in an average week, and responses were categorized into two groups 
(<3/week, 3+/week), based on the national exercise recommendations of the Taiwan government 
[31]. 
Physical and mental health measures included self-reports of current chronic diseases, 
cognitive function, depressive symptoms and biomarkers assessed during physical examinations. 
We summed the number of current chronic diseases including high blood pressure, diabetes, heart 
diseases, stroke, cancer, arthritis, gout, and osteoporosis. 
Cognitive functioning was assessed with the Short Portable Mental Status Questionnaire 
(SPMSQ), which assesses global cognitive function. It requires participants to provide their 
address, age, date, day of the week, the current president, the last president, mother’s maiden 
name, and to count backwards from 20 in steps of 3 a total of four times [31]. The number of 
incorrect responses was summed, with higher scores indicating poor cognitive function. 
Participants with a score ≥ 4 were categorized as having cognitive impairment [32]. 
Depressive symptoms were measured using a 10-item Chinese version of the Center for 
Epidemiologic Studies of Depression Scale (CES-D), which has been validated and used in 
 previous studies [24, 33, 34]. Each item in the CES-D was rated on a 4-point scale ranging from 0 
to 3, with higher total scores representing higher depressive symptoms. Participants with a score 
≥ 10 were categorized as having depressive symptoms [35]. 
Biomarkers included homocysteine and inflammatory markers (high-sensitivity C-reactive 
protein (hsCRP) and interleukin-6 (IL 6)), which were obtained from fasting blood samples based 
on assays described in previous studies [19, 36]. These biomarkers were treated as continuous 
variables with natural log transformations for skewed distributions in the regression analyses. 
These variables were selected as covariates on the basis of documented associations with 
physical difficulties [3-5, 7-10, 37]. 
Statistical analyses 
Descriptive statistics for all covariates, obesity, and APOE ε4 at baseline were calculated 
to characterize the participants. An online calculator was used to perform tests of Hardy–
Weinberg equilibrium and determine minor allele frequencies (Calculator Hardy-Weinberg 
equilibrium, 2012). Mann Whitney U test and Kruskal-Wallis tests were used to examine 
differences in scores of combined ADL difficulties due to the violation of normality. However, 
comparable results emerged with parametric analyses. Spearman’s correlations were conducted to 
test the univariate associations between continuous variables at baseline and subsequent 
difficulties in activities of daily living. The scores of combined ADLs were positively skewed 
and over-dispersed. Thus, negative binomial regressions were conducted to analyze the 
prospective associations of obesity and APOE ε4 with subsequent difficulties of combined ADLs. 
 Incident rate ratios (IRRs) (eB) were reported due to the nonlinearity of the negative binomial 
distribution in combined ADLs scores. 
The data were examined for evidence of multicollinearity with the variance inflation 
factors (VIF) and tolerance statistics. The VIF > 5 and tolerance values < 0.2 indicate there might 
be multicollinearity problems (van Vuuren, 2006). In this study, the VIF values ranged from 
1.039 to 1.852 and the lowest and highest tolerance values were .540 and .963, suggesting that 
multicollinearity was not an issue. 
Two separate negative binomial regressions were computed. The first regression 
examined the associations of baseline obesity and APOE ε4 with combined ADL difficulties after 
six years controlling for socio-demographic variables, cognitive function, health-related 
behaviors, health status, and difficulties in ADLs at baseline. Then, in order to examine the 
associations between the combination of obesity and APOE ε4 on subsequent difficulties of 
activities of daily living, participants were categorized by BMI category across APOE ε4 groups. 
Since no significant difference was found between overweight and normal/underweight 
individuals in the first regression analysis, BMI was further grouped into two categories (obese, 
non-obese). Four groups were then created: APOE ε4 carrier / Obese, APOE ε4 carrier / 
Non-Obese, Non-carrier / Obese, and Non-carrier / Non-Obese). The second regression was 
performed to predict subsequent difficulties in combined ADLs by entering this classification 
with multivariate adjustments. 
We conducted sensitivity analyses by separating ADLs and IADLs as outcome variables 
 in addition to the combined ADLs since the abilities required for ADL and IADLs are distinct in 
concept. We also carried out sensitivity analyses after excluding those with any difficulties in 
combined ADLs at baseline. All analyses were conducted using IBM SPSS statistics 22 and a 
p-value less than 0.05 was considered as statistically significant in this study. 
Results 
Table 1 provides information about characteristics of participants at baseline and the 
relationship between each variable and the number of combined ADL difficulties at follow-up. 
The prevalence of obesity and overweight at baseline was 23.3% and 30.2%. The frequencies of 
ε2, ε3 and ε4 alleles were 8.1, 84.0 and 7.8%, respectively and 15.3% of participants were 
carriers of the ε4 allele. The distribution of the APOE alleles confirmed to Hardy-Weinberg 
equilibrium with chi-square=1.93, df=5, and p=0.59. 
In the univariate analyses, all variables except for baseline exercise, homocysteine, hsCRP, 
and APOE ε4 were significantly associated with subsequent difficulties in combined ADLs 
(p<0.05 or greater). Participants who had greater ADL difficulties at follow-up tended to be older, 
female, less educated, not married, non-smokers, non-drinkers, were obese, had cognitive 
impairment, depressive symptoms, higher IL 6, and more chronic diseases. 
Table 1 
Results from the fully adjusted regression models with difficulties in combined ADLs as the 
outcome are summarized in table 2. APOE ε4 carriers had greater difficulties in combined ADLs 
(IRR =1.87, 95 % CI =1.40–2.51, p<0.001) than non-carriers (model 1). Obese but not 
 overweight older adults were more likely to have greater ADL difficulties (IRR =1.59, 95 % CI 
=1.20–2.10, p=0.001) compared with the normal/underweight group. The interaction between 
obesity and APOE ε4 was also significant (p= 0.040). Model 2 shows the association between the 
combination of obesity and APOE ε4 groups and subsequent difficulties in combined ADLs. 
Compared with the APOE ε4 non-carrier / non-obese group, the obese and non-obese APOE ε4 
carriers and obese APOE ε4 non-carriers had greater difficulties in combined ADLs (IRR =2.35, 
95 % CI =1.40–3.96, p=0.001; IRR =2.04, 95 % CI =1.45–2.88, p=<0.001; IRR =1.54, 95 % CI 
=1.17-2.03, p=0.002, respectively). This pattern is illustrated in Figure 1. 
Apart from obesity and APOE ε4, baseline difficulties in activities of daily living 
significantly predicted difficulties in combined ADLs at follow-up (p<0.001). Participants who 
were older, female, less educated, had cognitive impairment, depressive symptoms, higher 
homocysteine, higher IL 6, and more chronic diseases had greater difficulties in combined ADLs 
than the reference groups (all p< 0.05). 
Table 2 
Figure 1 
The results for separated ADLs and IADLs showed that APOE ε4 carriers had greater 
subsequent difficulties in ADLs (IRR =3.81, 95 % CI =2.32-6.27, p<0.001) and IADLs (IRR 
=1.64, 95 % CI =1.22-2.21, p<0.001) than non-carriers. The same trends were found for BMI / 
APOE ε4 categories in the analyses of ADLs and IADLs as on the main analysis, though effects 
were stronger for ADLs than IADLs (table 3). 
 Table 3 
The sensitivity analyses that excluded participants with any difficulties in combined ADLs 
at baseline (table 4) yielded a similar result for APOE ε4, with APOE ε4 carriers having greater 
subsequent difficulties in combined ADLs (IRR =2.20, 95 % CI =1.53–3.15, p<0.001). The obese 
and non-obese APOE ε4 carriers and obese APOE ε4 non-carriers also had greater difficulties in 
combined ADLs compared with the APOE ε4 non-carrier / non-obese group (IRR =2.18, 95 % CI 
=1.17–4.06, p=0.014; IRR =2.58, 95 % CI =1.69–3.94, p<0.001; IRR =1.48, 95 % CI =1.01-2.16, 
p=0.042, respectively). 
Table 4 
Discussion 
This longitudinal six-year follow-up study examined obesity, APOE ε4, and difficulties in 
ADLs controlling for a number of covariates among older adults. The results revealed that APOE 
ε4 carriers and obese individuals were at higher risk of increased difficulties in combined ADLs. 
When we further looked at the associations between the combination of obesity and APOE ε4 
groups and physical difficulties, obese older adults without APOE ε4 were more likely to have 
greater subsequent difficulties in ADLs than non-obese non-carriers. Among APOE ε4 carriers, 
obesity was not a significant predictor of future ADLs. The main analyses combined ADLs and 
IADLs, but sensitivity analyses indicated that similar patterns were present in both categories of 
disability. 
It has been reported that the presence of APOE ε4 is associated with greater physical 
 difficulties [12, 14]. However, two studies found no significant associations between APOE ε4 
and physical difficulties with the same population of older Taiwanese adults as the one 
investigated here [16, 17]. One study was cross-sectional [17], while the other involved only 
three years of follow-up [16]. The number of participants developing difficulties with IADLs and 
ADLs was small (n= 79 and 35, respectively) and the number of APOE ε4 carriers was even 
smaller (n=15 and 2, respectively), limiting statistical power. Our study was carried out over six 
years and the outcome used combined scores of ADLs and IALDs, which might increase 
sensitivity [27]. 
This is the first report to reveal an association between the combination of obesity and 
APOE ε4 and future difficulties in ADLs. Among the APOE ε4 non-carriers, obese older adults 
were more likely to have greater difficulties in ADLs than non-obese. On the other hand, among 
the APOE ε4 carriers, obesity might not impact on risk of difficulties in ADLs. One possible 
explanation may be that APOE ε4 genotype is related to a number of adverse health outcomes, 
including cognitive impairment [38, 39] and chronic diseases [40-42]. Cognitive impairment has 
been shown to have an independent impact on ADL [43]. Chronic diseases (such as stroke, 
diabetes, and arthritis) may also result in physiological impairment, which limits physical abilities 
[44, 45]. Older adults are particularly susceptible to problems of cognitive impairment and 
chronic diseases with advancing age, so it is possible that obesity is not a strong predictor among 
APOE ε4 carriers because of the potential effects of these factors. 
Among the covariates, participants who did not smoke or consume alcohol had greater 
 difficulties in activities of daily living at follow-up in the univarate analyses. However, the results 
became non-significant in the multivariate models. This study only considered the current 
smoking and drinking status without identifying former and never smokers or former drinkers. 
People with poor health are more likely to quit smoking and drinking [28]. Moreover, this study 
also showed that cognitive impairment, depressive symptoms, more chronic diseases, and higher 
homocysteine were associated with physical difficulties in older adults. 
Although this study extends our understanding of the associations between obesity, APOE ε4, 
and difficulties of ADLs, it has a number of difficulties. Around 37.5% of participants did not 
attend the follow-up survey. The main reason for the high attrition rate was a high mortality 
among this study sample (n=177, 17.3%). No significant differences were found between the 
dropouts and completers in terms of sex, obesity status, and the presence of APOE ε4. However, 
the dropouts were more likely to be older, had lower education levels, more chronic diseases, and 
greater depressive symptoms at baseline. Since these subgroups of population tend to be less 
healthy, selection bias may lead to underestimation of the association between obesity and 
difficulties of ADLs. Several other factors might mediate or moderate the effects of APOE 
genotype or/and obesity on activities of daily living for older adults. We included cognitive 
function and several health conditions as covariates, and found that the associations of APOE 
genotype and adiposity were independent of these variables. But we did not test moderation or 
mediation directly. Furthermore, this observational study cannot establish definitive conclusions 
about the direction of causality. Obesity was only assessed at baseline, and data were only 
 available for a follow-up period of six years. Other time intervals or multiple assessments would 
have been desirable. Subsequent changes in obesity status in the years before follow-up may 
yield different results. Well-designed randomized control trials and large-scale cohort studies 
with more repeated measures are encouraged to confirm these findings. 
In sum, this study provides evidence that obese older adults without APOE ε4 are more 
likely to have greater subsequent difficulties in ADLs than non-obese non-carriers. Among the 
APOE ε4 carriers, obesity did not predict future physical difficulties. The interaction between 
genotype and obesity phenotype adds new information about the determinants of physical 
impairments. 
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 Table 1 Characteristics of participants in 2000 with difficulties in activities of daily living in 2006 
Baseline Variables 
Characteristics of 
participants in 2000 
Difficulties in activities of daily 
living in 2006 a 
n % n Mean ± SD p b
Age   <.001
<65 288 45.1% 287 1.03±2.58 
65-74 242 37.9% 241 3.39±6.34 
≥75 109 17.1% 109 7.13±9.26 
Sex   <.001
   Female 278 43.5% 277 4.10±6.85 
   Male  361 56.5% 360 2.10±5.35 
Years of schooling   <.001
   No schooling  188 29.4% 187 5.39±7.95 
   1-6 years 272 42.6% 271 2.24±5.08 
   7+ years 179 28.0% 179 1.54±4.44 
Marital status   <.001
   Others 149 23.3% 148 5.05±7.98 
   Married 490 76.7% 489 2.34±5.29 
Smoker   <.001
   Yes   139 21.8% 138 1.80±5.18 
   No 499 78.2% 498 3.30±6.33 
Alcohol consumer   <.001
   Yes 159 25.0% 159 1.75±5.03 
   No  477 75.0% 475 3.39±6.41 
Exercise   .824
   0-2 times/week 303 47.4% 301 3.18±6.64 
   3+ times/week 336 52.6% 336 2.78±5.62 
Cognitive function   <.001
Normal 619 98.3% 617 2.69±5.63 
Abnormal 11 1.7% 11 14.73±13.25 
Depressive symptoms   <.001
Normal 526 83.4% 525 2.18±4.98 
Abnormal 105 16.6% 104 6.52±8.93 
Homocysteine (umol/L) 632 15.39±5.96 c 630 ρ=.043 d .286
hsCRP (mg/L) e 628 2.66±5.44 c 626 ρ=.053 d .184 
IL 6 (pg/ml) f 610 3.16±3.28 c 608 ρ=.132 d .001
N. of Chronic disease 639 0.76±0.90 c 637 ρ=.240 d <.001
APOE ε4 g   .113
Carrier 98 15.3% 97 3.54±6.63 
Non-carrier 541 84.7% 540 2.87±6.03 
BMI h   .023
Obese 149 23.3% 149 4.20±7.59 
Overweight 193 30.2% 193 3.09±6.28 
Normal/underweight  297 46.5% 295 2.27±5.00 
APOE ε4_ BMI   .106
Carrier_Obese 26 4.1% 26 4.58±8.71 
Carrier_Non-obese 72 11.3% 71 3.15±5.70 
Non-carrier_Obese  123 19.2% 123 4.12±7.36 
Non-carrier_Non-obese 418 65.4% 417 2.50±5.53 
a: Mean± SD: 2.97± 6.12 (score range: 0-36); b: Mann Whitney U test or Kruskal-Wallis test; c: 
Mean ± SD; d: Spearman’s correlation; e: high-sensitivity C-reactive protein; f: interleukin-6; g: 
apolipoprotein E ε4; h: body mass index.
 Table 2. Negative binomial regressions for predicting difficulties in activities of daily living 
 
Baseline variables 
Model 1 (n=594) Model 2 (n=594) 
IRR a 95％CI b p IRR a 95％CI b p 
Age <.001  <.001
<65 .23 .17-.33 <.001 .23 .17-.32 <.001
65-74 .61 .46-.83 .001 .59 .44-.80 .001
≥75 1 1  
Sex .006  .004
Female 1.51 1.13-2.02 1.53 1.14-2.05 
Male  1 1  
Years of schooling <.001  <.001
No schooling  2.09 1.52-2.86 <.001 2.04 1.49-2.79 <.001
1-6 years 1.73 1.29-2.31 <.001 1.74 1.30-2.33 <.001
7+ years 1 1  
Marital status .230  .225
Others .85 .65-1.11 .85 .65-1.11 
Married 1 1  
Smoker .890  .943
Yes 1.02 .74-1.42 .99 .71-1.37 
No 1 1  
Alcohol consumer .145  .134
Yes .81 .60-1.08 .80 .60-1.07 
No 1 1  
Exercise .817  .824
0-2 times/week .97 .78-1.22 .98 .78-1.22 
3+ times/week 1 1  
Cognitive function .009  .009
Normal .40 .20-.80 .41 .21-.80 
Abnormal 1 1  
Depressive symptoms .014  .010
Normal .70 .52-.93 .68 .51-.91 
Abnormal 1 1  
Homocysteine_log (umol/L) 2.35 1.62-3.41 <.001 2.40 1.65-3.50 <.001
hsCRP_log (mg/L) c .95 .87-1.03 .203 .96 .89-1.04 .333
IL 6_log (pg/ml) d 1.22 1.00-1.48 .050 1.20 .99-1.46 .066
N. of Chronic disease 1.14 1.01-1.29 .031 1.15 1.02-1.30 .021
Baseline ADL&IADL e 1.19 1.13-1.26 <.001 1.19 1.12-1.26 <.001
APOE ε4 f <.001  
Carrier 1.87 1.40-2.51  
Non-carrier 1  
BMI g .005  
Obese 1.59 1.20-2.10 .001  
Overweight 1.19 .91-1.56 .198  
Normal/underweight  1  
APOE ε4_BMI  <.001
Carrier_Obese 2.35 1.40-3.96 .001
Carrier_Non-obese 2.04 1.45-2.88 <.001
Non-carrier_Obese  1.54 1.17-2.03 .002
Non-carrier_Non-obese 1  
a: Incident rate ratio; b: confidence interval; c: high-sensitivity C-reactive protein; d: interleukin-6; e: 
basic and instrumental activities of daily living; f: apolipoprotein E ε4; g: body mass index. 
1 
Table 3. Sensitivity analyses for predicting future difficulties in activities of daily living 
(Separating basic and instrumental activities of daily living) 
Baseline variables 
Model 1 Model 2 
IRR a 95％CI b p IRR a 95％CI b p
Basic activities of daily living   
APOE ε4 c <.001   
Carrier 3.81 2.32-6.27   
Non-carrier 1   
BMI d <.001   
Obese 4.48 2.79-7.19 <.001   
Overweight 1.33 .80-2.19 .273   
Normal/underweight  1   
APOE ε4_BMI   <.001
Carrier_Obese 11.54 5.08-26.18 <.001
Carrier_Non-obese 4.63 2.49-8.63 <.001
Non-carrier_Obese  4.49 2.80-7.21 <.001
Non-carrier_Non-obese 1  
Instrumental activities of daily living   
APOE ε4 c <.001   
Carrier 1.64 1.22-2.21   
Non-carrier 1   
BMI d .104   
Obese 1.36 1.02-1.81 .034   
Overweight 1.15 .88-1.50 .314   
Normal/underweight  1   
APOE ε4_BMI   .002
Carrier_Obese 1.85 1.09-3.16 .024
Carrier_Non-obese 1.76 1.24-2.49 .002
Non-carrier_Obese  1.33 1.00-1.77 .048
Non-carrier_Non-obese 1  
a: Incident rate ratio; b: confidence interval; c: apolipoprotein E ε4; d: body mass index. 
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Table 4. Sensitivity analyses for examining subsequent difficulties in activities of daily 
living 
(Excluding any difficulties with activities of daily living at baseline) 
Baseline variables 
Model1 Model 2 
IRR a 95％CI b p IRR a 95％CI b p
APOE ε4 c  <.001  
Carrier 2.20 1.53-3.15  
Non-carrier 1  
BMI d  .092  
Obese 1.47 1.02-2.11 .039  
Overweight 1.30 .92-1.84 .132  
Normal/underweight  1  
APOE ε4_BMI   <.001
Carrier_Obese  2.18 1.17-4.06 .014
Carrier_Non-obese  2.58 1.69-3.94 <.001
Non-carrier_Obese   1.48 1.01-2.16 .042
Non-carrier_Non-obese  1  
a: Incident rate ratio; b: confidence 
interval; c: apolipoprotein E ε4; d: body 
mass index. 
 
